Equine herpesvirus 2 (EHV-2) infection in thoroughbred horses in Argentina
Tóm tắt
Equine herpesvirus 2 is a gamma-herpesvirus that infects horses worldwide. Although EHV-2 has been implicated in immunosuppression in foals, upper respiratory tract disease, conjunctivitis, general malaise and poor performance, its precise role as a pathogen remains uncertain. The purpose of the present study was to analyse the incidence of EHV-2 in an Argentinean horse population and correlate it with age and clinical status of the animals. A serological study on 153 thoroughbred racing horses confirmed the presence of EHV-2 in the Argentinean equine population. A virus neutralization test showed a total of 79.7 % animals were sero-positive for EHV-2. An increase in antibodies titre with age as well as infection at earlier ages were observed. EHV-2 was isolated from 2 out of 22 nasal swabs from horses showing respiratory symptoms. The virus grew slowly and showed characteristic cytopathic effect after several blind passages on RK13 cells. The identity of the isolates was confirmed by nested PCR and restriction enzyme assay (REA). This is the first report on the presence of EHV-2 in Argentina and adds new data to the virus distribution map. Though EHV-2 was isolated from foals showing respiratory symptoms, further studies are needed to unequivocally associate this virus with clinical symptoms.
Tài liệu tham khảo
Plummer G, Waterson AP: Equine herpesvirus. Virol. 1963, 19: 412-416. 10.1016/0042-6822(63)90083-7.
Kono Y, Kobayashi K: Cytopathogenic equine orphan (CEO) virus in horse kidney cell culture I. Isolation and properties. Natl Inst An Health Q Japan. 1964, 4: 10-20.
Studdert MJ, Turner AJ, Peterson JE: Equine herpesvirus 1. Isolation and characterization of equine rhinopneumonitis virus and other equine herpesvirus from horses. Aust Vet J. 1970, 46: 83-89.
Horner GW, Hunter R, O'Flaherty JD, Dickinson LG: Isolation of equine herpesvirus from horses with respiratory disease. N Z Vet J. 1976, 24: 171-176.
Karpas A: Characterization of a new herpes-like virus isolated from foal kidney. Ann Inst Pasteur, Paris. 1966, 110: 688-696.
Petzoldt K: Die Virusausscheidg beim Stutenabort (Rhinopneumonitis). Arch Exp Vetarmed. 1967, 21: 115-119.
Thein P: The association of EHV-2 infection with keratitis and research on the occurrence of equine coital exanthema (EHV-3) of horses in Germany. Equine infectious disease IV. Edited by: Bryans JT, Gerber H. Princeton New Jersey: Veterinary Publications; 1978:33-41.
Kemeny LJ, Pearson JE: Isolation of herpesvirus from equine leucocytes: comparison with equine rhinopneumonitis virus. Can J Comp Med. 1970, 34: 59-65.
Roberts AW, Whitenack DL, Carter GR: Recovery of adenoviruses and slow herpesviruses from horses having respiratory tract infection. Am J Ve t Res. 1974, 35: 1169-1172.
Sherman J, Thorsen J, Barnum JA, Mitchell WR, Ingram DG: Infectious causes of equine respiratory disease on Ontario Standardbred racetracks. J Clin Microbiol. 1977, 5: 285-289.
Pàlfi V, Belák S, Molnár T: Isolation of equine herpesvirus type 2 from foals showing respiratory symptoms. Zentralbl Veterinarmed B. 1978, 25: 165-167.
Rusczcyk A, Cywinska A, Banbura MW: Equine herpes virus 2 infection in horse populations in Poland. Acta Virol. 2004, 48 (3): 189-192.
Plummer G, Goodheart CR, Studdert MJ: Equine herpesviruses: antigenic relationships and deoxyribonucleic acid densities. Infect Immu. 1973, 8: 621-627.
Studdert MJ: Comparative aspects of equine herpesviruses. Cornell Vet. 1974, 64: 94-122.
Blakeslee JR, Olsen RG, Mc Allister ES, Fassbender J, Dennis R: Evidence of respiratory tract infection induced by equine herpesvirus type 2 in the horse. Can J Microbiol. 1975, 21: 1940-1946.
Belák S, Pàlfi V, Tuboly S, Bartha L: Passive immunization of foals to prevent respiratory disease caused by equine herpesvirus type 2. Zentralbl Veterinarmed B. 1980, 27: 826-830.
Bagust TJ, Pascoe RR, Harden TJ: Studies on equine herpesviruses 3. The incidence in Queensland of three different equine herpesvirus infections. Aust Vet J. 1972, 48: 47-53.
Mc Guire TC, Crawford TB, Henson JB: Prevalence of antibodies to herpesvirus types 1 and 2, arteritis and infectious anemia viral antigens in equine serum. Am J Vet Res. 1974, 35: 181-185.
Harden TJ, Bagust TJ, Pascoe RR, Spradbow PB: Studies on equine herpesvirus 5. Isolation and characterization of slowly cytopathic equine herpesviruses in Queensland. Austr Vet J. 1974, 50: 483-488.
Roeder PL, Scott GR: The prevalence of equid herpes virus 2 infections. The Vet Rec. 1975, 96: 404-405.
Browning GF, Studdert MJ: Equine herpesvirus 2 (Equine Cytomegalovirus). Vet Bull. 1998, 58: 775-790.
Agius CT, Studdert MJ: Equine herpesviruses 2 and 5: comparisons with other members of subfamily gamma-herpesvirinae. Adv Virus Res. 1994, 44: 357-379.
Browning GF, Studdert MJ: Physical mapping of a genome of equine herpesvirus type 2 (equine cytomegalovirus). Arch Virol. 1989, 104: 77-86. 10.1007/BF01313809.
Collinson PN, O'Reilly JL, Ficorilli N, Studdert MJ: Isolations of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratoconjunctivitis. J Am Vet Med Assoc. 1994, 205: 329-331.
Nordenghran A, Kingeborn B, Lindholm A, Merza M: The use of neutralizing monoclonal antibody to detect infections of equine herpesvirus type 2 (EHV-2). J Vet Diagn Invest. 2001, 13: 389-393.
Reed L, Muench H: A simple method of estimating fifty per cent end points. Am J Hyg. 1938, 27: 493.
Borchers K, Wolfinger U, Goltz M, Broll H, Ludwig H: Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch Virol. 1997, 142: 917-928. 10.1007/s007050050128.
Sokal RR, Rohlf FJ: Biometry. 2nd edition. Freeman, New York; 1981:1-859.
Winer BJ: Statistical Principles in Experimental Design. Mac Graw Hill, New York; 1971:907-2